Politician trade (House)

Johnson & Johnson (JNJ)Rep. Lloyd Doggett (TX37) disclosed a purchase $1K–$15K

Rep. Lloyd Doggett (TX37) disclosed a purchase of Johnson & Johnson in the $1K–$15K range.

$1,001–$15,000
Reported range · official band, not an exact amount
27 days
Disclosure lag
Traded
Jun 9, 2026
Disclosed
Jul 6, 2026

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Dec 16, 2025Federal contractDepartment of Veterans Affairs awarded Johnson & Johnson: $0 obligated to date
  2. Feb 23, 2026Federal contract · $371K obligatedDepartment of Defense awarded Johnson & Johnson: $371K obligated to date
  3. Feb 26, 2026Federal contract · $272K obligatedDepartment of Defense awarded Johnson & Johnson: $272K obligated to date
  4. Mar 4, 2026Federal contract · $205K obligatedDepartment of Defense awarded Johnson & Johnson: $205K obligated to date
  5. Mar 16, 2026Federal contract · $205K obligatedDepartment of Defense awarded Johnson & Johnson: $205K obligated to date
  6. Mar 19, 2026CongressDisclosed partial sale of JNJ — reported range $1,001 - $15,000
  7. Mar 26, 2026CongressDisclosed partial sale of JNJ — reported range $1,001 - $15,000
  8. Mar 27, 2026CongressDisclosed purchase of JNJ — reported range $15,001 - $50,000
  9. Mar 30, 2026CongressDisclosed purchase of JNJ — reported range $1,001 - $15,000
  10. Apr 10, 2026Federal contract · $198K obligatedDepartment of Defense awarded Johnson & Johnson: $198K obligated to date
  11. Apr 14, 2026Company filing · Form 8-K · Results, Other newsReported its results, and reported other company news
  12. May 1, 20265% stakeVanguard Capital Management reported a passive stake (13G) of 7.5%
  13. May 28, 2026Federal contract · $21K obligatedDepartment of Veterans Affairs awarded Johnson & Johnson: $21K obligated to date
  14. Jun 2, 2026CongressDisclosed partial sale of JNJ — reported range $1,001 - $15,000
  15. Jun 9, 2026 · this disclosureCongressDisclosed purchase of JNJ — reported range $1,001 - $15,000

What came next

  1. Jun 11, 2026FDAFDA device clearance: MAXFRAME AUTOSTRUT™ with Bluetooth Multi-Axial Correction System
  2. Jun 11, 2026Insider · First sale since 2023Officer sold ~$2.41M of JNJ shares in the open market
  3. Jun 25, 2026FDAFDA device clearance: Coated VICRYL™ (Polyglactin 910) Plus Antibacterial Suture
  4. Jun 25, 2026FDAFDA device clearance: ATTUNE Total Knee System; ATTUNE Cementless Knee System
  5. Jun 25, 2026FDAFDA device clearance: VELYS™ Robotic-Assisted Solution
  6. Jun 29, 2026CongressDisclosed partial sale of JNJ — reported range $1,001 - $15,000
  7. Jul 15, 2026Company filing · Form 8-K · ResultsReported its results
  8. Jul 20, 2026InsiderOfficer sold ~$5.79M of JNJ shares in the open market
  9. Jul 23, 2026FDARecall: Velys Enabling Tech Robotic-Assist Station REF: 451611001
  10. Jul 25, 2026FDAFDA device clearance: MONARCH™ Platform (MON-000008)
  11. Jul 27, 2026FDAFDA device clearance: Shockwave Intravascular Lithotripsy (IVL) System with the Shockwave E8 Peripheral IVL Catheter
  12. Jul 30, 2026Federal contract · $385K obligatedDepartment of Veterans Affairs awarded Johnson & Johnson: $385K obligated to date
  13. Jul 30, 2026CongressDisclosed sale of JNJ — reported range $1,001 - $15,000
  14. Jul 31, 2026FDARecall: HEALON EndoCoat PRO, REF: 10300012 (US/CAN) HEALON DUET PRO II, REF: 10300016 (US/CAN) HEALON EndoCoat PRO, REF: 10301012 (EU); HEALON DUET PRO II, REF: 103010…
  15. Jul 31, 2026Federal contract · $21K obligatedDepartment of Veterans Affairs awarded Johnson & Johnson: $21K obligated to date
  16. Aug 4, 2026Company filing · Form 8-K · Executive changeChanged a top executive or board member“On August 4, 2026, the Company announced that Jennifer Taubert will retire from her position as Executive Vice President, Worldwide Chairman, Innovative Medicine and member of the Executive Committee effective September 1, 2026.”
  17. Aug 5, 2026Insider · 1 personInsiders: 2 sales (~$12.5M)
  18. Aug 6, 2026Insider · 1 personInsiders: 2 sales (~$4.1M)
  19. Aug 12, 2026FDARecall: Automated Impella Controller (AIC) with the below product descriptions and corresponding Product Codes. 1. Impella Controller, Packaged, CA; Product Code: 0042…
  20. Aug 12, 2026FDARecall: Impella Optical Controller with the below product descriptions and corresponding Product Codes. 1. Impella Optical Controller, Packaged, AU; Product Code: 0042…
View the official recordHouse Clerk periodic transaction report

How to read House Clerk periodic transaction report

The STOCK Act is a 2012 US law that requires members of Congress, and some senior staff, to publicly report their stock trades, and those of their spouse and dependent children, within 45 days.

Full guide: What is the STOCK Act?

What else is on file for Johnson & Johnson

For Johnson & Johnson, OQRO holds 15 insider filings (SEC Form 4 or Form 144), 8 Congress trade reports, 167 fund holdings reports (13F) and 5 federal contract awards dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its JNJ page.

Other recent filings by Rep. Lloyd Doggett (TX37)

The full history of Rep. Lloyd Doggett (TX37) is on the profile page.

How this filing works

Other disclosures at Johnson & Johnson

Everything OQRO holds on this company is on its JNJ page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

OQRO Pro is a paid subscription. You see the price before you pay

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data